{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:14:01Z","timestamp":1794651241967,"version":"4.9.1"},"reference-count":25,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2010,3,13]],"date-time":"2010-03-13T00:00:00Z","timestamp":1268438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2010,6]]},"abstract":"<jats:sec><jats:label\/><jats:p> <jats:italic>Aliment Pharmacol Ther<\/jats:italic>\u2002<jats:bold>31<\/jats:bold>, 1330\u20131336<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Occult myeloproliferative disorders (MPD) are present in 25% of patients with chronic portal, splenic and mesenteric venous thrombosis (PSMVT). A somatic mutation of JAK2 (JAK2V617F) can be used to identify patients with latent MPD.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold> We evaluated the prevalence and clinical significance of JAK2V617F in patients with chronic PSMVT.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Allele\u2010specific polymerase chain reaction was performed to screen for JAK2V617F.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Thirty\u2010five patients were tested for JAK2V617F. The underlying pro\u2010coagulant condition was MPD in seven of 35 (20.0%) patients; other aetiologies included hereditary thrombophilia (<jats:italic>n<\/jats:italic>\u2003=\u20035), chronic pancreatitis (<jats:italic>n<\/jats:italic>\u2003=\u20032), liver abscess (<jats:italic>n<\/jats:italic>\u2003=\u20031) and umbilical vein sepsis (<jats:italic>n<\/jats:italic>\u2003=\u20033). The remainder were labelled idiopathic, i.e. 17\/35 (48.6%) patients. JAK2V617F was detected in 16\/35 (45.7%) patients: seven of seven (100%) with MPD, two of 11 (18.1%) with non\u2010MPD acquired conditions and seven of 17 (41.2%) with \u2018idiopathic\u2019 chronic PSMVT. Mean haemoglobin concentration (<jats:italic>P<\/jats:italic>\u2003=\u20030.04), haematocrit (<jats:italic>P<\/jats:italic>\u2003=\u20030.04), white cell count (<jats:italic>P<\/jats:italic>\u2003=\u20030.002) and platelet count (<jats:italic>P<\/jats:italic>\u2003=\u20030.05) were significantly higher in patients with JAK2V617F. None of the seven patients with latent MPD have progressed to overt MPD over median follow\u2010up of 85\u2003months.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> JAK2V617F occurs in 41% of patients with idiopathic chronic portal, splenic and mesenteric venous thrombosis, confirming the presence of latent myeloproliferative disorders, and should form part of the routine pro\u2010coagulant screen.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2036.2010.04299.x","type":"journal-article","created":{"date-parts":[[2010,5,24]],"date-time":"2010-05-24T04:04:05Z","timestamp":1274673845000},"page":"1330-1336","source":"Crossref","is-referenced-by-count":26,"title":["The prevalence of the activating <i>JAK<\/i>2 tyrosine kinase mutation in chronic porto\u2010splenomesenteric venous thrombosis"],"prefix":"10.1111","volume":"31","author":[{"given":"D. W.","family":"ORR","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. K.","family":"PATEL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. C.","family":"LEA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. H.","family":"WESTBROOK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. G.","family":"O\u2019GRADY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. D.","family":"HEATON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"PAGLIUCA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. J.","family":"MUFTI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"HENEGHAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,5,20]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510310307"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04116.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2004.02.008"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/107602960000600105"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002779900136"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.09.030"},{"key":"e_1_2_6_8_2","first-page":"981","article-title":"In vitro colony culture and chromosomal studies in hepatic and portal vein thrombosis \u2013 possible evidence of an occult myeloproliferative state","volume":"76","author":"Pagliuca A","year":"1990","journal-title":"Q J Med"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051113"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)71142-9"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature03546"},{"key":"e_1_2_6_12_2","volume-title":"World Health Organization of Tumours. Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues","author":"Jaffe ES","year":"2001"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-009-0933-y"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-008-0225-y"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH08-07-0451"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-553X.2007.00973.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21435"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.02277.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-12-064287"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05764.x"},{"key":"e_1_2_6_21_2","first-page":"169","article-title":"Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status","volume":"91","author":"Arellano\u2010Rodrigo E","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_6_22_2","first-page":"372","article-title":"Portal vein thrombosis (PVT): a study of 20 non\u2010cirrhotic cases","volume":"135","author":"Kocher G","year":"2005","journal-title":"Swiss Med Wkly"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.21209"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11643"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-05-092502"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.04.008"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2010.04299.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2010.04299.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2010.04299.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T14:07:54Z","timestamp":1694786874000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2010.04299.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,20]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["10.1111\/j.1365-2036.2010.04299.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2010.04299.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,20]]}}}